The Cost of Bladder Cancer Care Is Rising. Could Value-Based Care Models Help?
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
As many as 10% of early-onset metastatic colorectal cancer cases may be attributable to undiagnosed inflammatory bowel disease, a study suggests.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
The expansion of Medicaid eligibility was associated with a nearly 3-fold increase in the proportion of Medicaid-covered patients enrolled in cancer treatment trials.
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of HeLa cells.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Sister Mary Joseph nodule.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake for Kaposi sarcoma.
New research suggests aspirin may lower the risk for gastric adenocarcinoma in women but not in men.